{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:45:11Z","timestamp":1793051111057,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.biomaterials.2024.122924","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T19:38:52Z","timestamp":1730317132000},"page":"122924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nanoradiosentizers with X ray-actuatable supramolecular aptamer building units for programmable immunostimulatory T cell engagement"],"prefix":"10.1016","volume":"315","author":[{"given":"Jinming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijiao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9029-680X","authenticated-orcid":false,"given":"Kaiyong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9019-3314","authenticated-orcid":false,"given":"Zhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.biomaterials.2024.122924_bib1","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1039\/D1CS01145F","article-title":"Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection","volume":"51","author":"Pan","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","article-title":"Cancer radiosensitizers","volume":"39","author":"Wang","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122924_bib3","first-page":"688","article-title":"Image-guided radiotherapy: from current concept to future perspectives","volume":"9","author":"Jaffray","year":"2012","journal-title":"Nat. Rev. Clin."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122924_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41590-019-0561-4","article-title":"Immunological impact of cell death signaling driven by radiation on the tumor microenvironment","volume":"21","author":"Rodriguez-Ruiz","year":"2020","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122924_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122924_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.trecan.2016.05.002","article-title":"Radiotherapy: changing the game in immunotherapy","volume":"2","author":"Demaria","year":"2016","journal-title":"Trends Cancer"},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122924_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41571-019-0238-9","article-title":"Assessing the interactions between radiotherapy and antitumour immunity","volume":"16","author":"Grassberger","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122924_bib8","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2015.2756","article-title":"Role of local radiation therapy in cancer immunotherapy","volume":"1","author":"Demaria","year":"2015","journal-title":"J JAMA Oncol"},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122924_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201401","article-title":"Radiation-induced immunogenic cell death for cancer radioimmunotherapy","volume":"7","author":"Liu","year":"2023","journal-title":"Small Methods"},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122924_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122924_bib11","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122924_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2024.122924_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100924","article-title":"Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression","volume":"35","author":"Chen","year":"2020","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122924_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122924_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41467-020-20243-8","article-title":"Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.biomaterials.2024.122924_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202109726","article-title":"High-Z-sensitized radiotherapy synergizes with the intervention of the pentose phosphate pathway for in situ tumor vaccination","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122924_bib18","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1158\/1078-0432.CCR-19-2034","article-title":"Radiotherapy and immunotherapy for cancer: from \"systemic\" to \"multisite\"","volume":"26","author":"Arina","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.biomaterials.2024.122924_bib19","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/1078-0432.CCR-19-1321","article-title":"Dendritic cells, the T-cell-inflamed tumor microenvironment, and immunotherapy treatment response","volume":"26","author":"Garris","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122924_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122924_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41551-018-0203-4","article-title":"Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy","volume":"2","author":"Lu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122924_bib22","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122924_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nrc1735","article-title":"Radiation and the microenvironment - tumorigenesis and therapy","volume":"5","author":"Barcellos-Hoff","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-021-01075-5","article-title":"Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies","volume":"14","author":"Heidbuechel","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13045-021-01084-4","article-title":"Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies","volume":"14","author":"Tian","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122924_bib26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.tips.2023.09.009","article-title":"Development of bispecific T cell engagers: harnessing quantitative systems pharmacology","volume":"44","author":"Qi","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2024.122924_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fonc.2020.00446","article-title":"Perspective: designing T-cell engagers with better therapeutic windows","volume":"10","author":"Vafa","year":"2020","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122924_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41571-020-0347-5","article-title":"T cell-engaging therapies - BiTEs and beyond","volume":"17","author":"Goebeler","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41392-023-01523-3","article-title":"Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122924_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/2159-8290.CD-18-0297","article-title":"CARs versus BiTEs: a comparison between T cell-redirection strategies for cancer treatment","volume":"8","author":"Slaney","year":"2018","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.biomaterials.2024.122924_bib31","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.4049\/jimmunol.158.8.3965","article-title":"Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3: tumor cell-dependent T cell stimulation and cytotoxic activity","volume":"158","author":"Mack","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122924_bib32","first-page":"S13","article-title":"Bispecific T-cell engagers for treatment of multiple myeloma","author":"Ravi","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40364-021-00294-9","article-title":"The landscape of bispecific T cell engager in cancer treatment","volume":"9","author":"Zhou","year":"2021","journal-title":"Biomark. Res."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122924_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood-2015-06-651380","article-title":"Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed\/refractory diffuse large B-cell lymphoma","volume":"127","author":"Viardot","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymthe.2016.10.011","article-title":"Masked chimeric antigen receptor for tumor-specific activation","volume":"25","author":"Han","year":"2017","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122924_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm.4015","article-title":"Prospects for gene-engineered T cell immunotherapy for solid cancers","volume":"22","author":"Klebanoff","year":"2016","journal-title":"Nat. Med."},{"issue":"608","key":"10.1016\/j.biomaterials.2024.122924_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd1524","article-title":"Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors","volume":"13","author":"Belmontes","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"645","key":"10.1016\/j.biomaterials.2024.122924_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn0402","article-title":"Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager","volume":"14","author":"Crook","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122924_bib40","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1039\/C4CS00357H","article-title":"Nucleic acid aptamers in cancer research, diagnosis and therapy","volume":"44","author":"Ma","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122924_bib41","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1039\/C5CS00645G","article-title":"Aptamer-integrated DNA nanostructures for biosensing, bioimaging and cancer therapy","volume":"45","author":"Meng","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2024.122924_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pharmtox-010716-104558","article-title":"Aptamers as therapeutics","volume":"57","author":"Nimjee","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"17","key":"10.1016\/j.biomaterials.2024.122924_bib43","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1002\/anie.201812885","article-title":"Fuel-responsive allosteric DNA-based aptamers for the transient release of ATP and cocaine","volume":"58","author":"Del Grosso","year":"2019","journal-title":"Angew. Chem. In.t Ed. Engl."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib44","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41467-020-15113-2","article-title":"Aptamer-based optical manipulation of protein subcellular localization in cells","volume":"11","author":"Xie","year":"2020","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.biomaterials.2024.122924_bib45","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1093\/nar\/26.15.3572","article-title":"Photocleavable aminotag phosphoramidites for 5'-termini DNA\/RNA labeling","volume":"26","author":"Olejnik","year":"1998","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib46","article-title":"A biomimetic approach for spatially controlled cell membrane engineering using fusogenic spherical nucleic acid","volume":"61","author":"Lin","year":"2022","journal-title":"Angew. Chem. In.t Ed. Engl."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122924_bib47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/bi00002a033","article-title":"A DNA aptamer that binds adenosine and ATP","volume":"34","author":"Huizenga","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.biomaterials.2024.122924_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bios.2019.03.047","article-title":"Novel strategy to improve the sensing performances of split ATP aptamer based fluorescent indicator displacement assay through enhanced molecular recognition","volume":"134","author":"Ma","year":"2019","journal-title":"Biosens. Bioelectron."},{"issue":"31","key":"10.1016\/j.biomaterials.2024.122924_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202201220","article-title":"Engineering aptamers with selectively enhanced biostability in the tumor microenvironment","volume":"61","author":"Xie","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122924_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1039\/C8CS00641E","article-title":"Transition metal compounds as cancer radiosensitizers","volume":"48","author":"Gill","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122924_bib51","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/1078-0432.CCR-12-2529","article-title":"\u03b3-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000)","volume":"19","author":"Wu","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-020-00897-z","article-title":"Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A\/STAT3 in advanced-stage colorectal cancer patients","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122924_bib53","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.semcancer.2021.12.011","article-title":"Multifaceted role of chemokines in solid tumors: from biology to therapy","volume":"86","author":"Raza","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"Supplement 1","key":"10.1016\/j.biomaterials.2024.122924_bib54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2021-153222","article-title":"Targeted radiation evokes catecholamine production triggering systemic inflammatory responses","volume":"138","author":"Kawano","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122924_bib55","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-23-3206","article-title":"Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites","volume":"30","author":"Hou","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"Supplement_1","key":"10.1016\/j.biomaterials.2024.122924_bib56","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2019-131809","article-title":"Local irradiation induces systemic inflammatory response and alteration of the hematopoietic stem cell niche","volume":"134","author":"Kawano","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122924_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"1\u20133","key":"10.1016\/j.biomaterials.2024.122924_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3zeta signalosome and downstream signaling to PKCtheta","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122924_bib59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-023-01504-7","article-title":"Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy","volume":"16","author":"Bulliard","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122924_bib60","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41586-020-2851-2","article-title":"Immune receptor inhibition through enforced phosphatase recruitment","volume":"586","author":"Fernandes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2024.122924_bib61","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122924_bib62","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1200\/JCO.2013.51.7680","article-title":"Restoring antitumor immunity via PD-1 blockade after autologous stem-cell transplantation for diffuse large B-cell lymphoma","volume":"31","author":"Jacobsen","year":"2013","journal-title":"J. Clin. Oncol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224004587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224004587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T19:14:18Z","timestamp":1735067658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224004587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":62,"alternative-id":["S0142961224004587"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122924","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoradiosentizers with X ray-actuatable supramolecular aptamer building units for programmable immunostimulatory T cell engagement","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122924"}}